CEO Update on Financial Results

Little Green Pharma Ltd (ASX: LGP, “LGP” or the “Company”) is pleased to provide a recording of Chief Executive Officer Paul Long providing commentary on the Company’s Half Year financial results, which have been released to market this morning.

As part of the video update, Mr. Long discusses LGP’s accelerating growth over the period, which saw the Company deliver a 40% increase in revenue to $12.8m during the half, as well as positive EBITDA of $700,000.

In addition, Mr. Long will also provide a further update on Little Green Pharma’s activities in the strategic and highly lucrative European medicinal cannabis markets, including the significant demand experienced in regions such as Germany and Poland. LGP has also had a strong involvement with a French Government-backed trial which is anticipated to pave the way for the product within French healthcare system.